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Endoscopic sinus surgeryAbstract Fibrous dysplasia is an uncommon benign tumour in the nasal cavity. Due to adjacent
vital soft tissue structures surgery is often the treatment of choice. We report a rare case of polyos-
totic fibrous dysplasia of the mandible and the ethmoid bone including nasal bony septum with
intracranial expansion, and include a review of the literature. The tumour was successfully resected
using a combined transnasal and craniotomy approach. Fibrous dysplasia is a rare benign tumour
in the head and neck region, which often limits its growth during the follow-up period. Careful
monitoring of the patient is necessary because in some rare cases there can be severe symptoms
due to the growth of the tumour, which are indications of immediate surgery in the head and neck
region.
 2015 Egyptian Society of Ear, Nose, Throat and Allied Sciences. Production and hosting by Elsevier B.V.
All rights reserved.1. Introduction
Fibrous dysplasia is a benign uncommon disorder of a bone. It
accounts for about 2.5% of all bone tumours and 7.5% of
benign bone tumours.1,2 Two forms of this disorder have been
recognised. The monostotic form represents 70% of the cases
and is defined as having only one focus of involvement.
The most common sites affected are the femur and costae.
Polyostotic fibrous dysplasia is characterised by multiple foci
involving several bones. The polyostotic form is sometimes
associated with McCune Albright syndrome (MAS) represent-
ing as an endocrine disorder and cafe´-au-lait spots.Histologically fibrous dysplasia has been described as an
overgrowth of nondescript fibrotic tissue with a secondary
phenomenon of bony metaplasia. More recently, it has been
shown that the underlying cause could be a complex derange-
ment in the function of the cells in the osteogenic lineage.3,4
A mutation in the subunit of an intracellular G-signalling
protein (Gs-a) leads to a loss of guanosine triphosphatase
activity of the Gs-a. This leads to increased intracellular cyclic
adenosine monophosphate (cAMP) production, increased cell
proliferation and inappropriate cell matrix production. It has
also been reported that cultured cells from MAS patients
secrete excessive interleukine-6 (IL-6) and have an increased
amount of intracellular cAMP.5
The natural course of the disease is variable. Although the
disease is usually progressive before the age of 30, some of
the lesions continue growing well into adulthood.6,7 There
are no uniformly accepted guidelines for treatment of this dis-.
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treatment. There are many reports of medical treatment with
bisphosphonates showing a decrease in pain from the lesions
but no resolution of the growth itself.8,9 Timing of surgical
treatment is variable depending on the location of the lesion
and the symptoms it causes.
We describe a very rare case of polyostotic fibrous dysplasia
involving the mandible and the base of the skull as well as the
ethmoid bone without any other signs of MAS.
2. Case report
A 14 year-old boy was referred from another hospital to the
Department of Otorhinolaryngology, Tampere University
Hospital for biopsies. The patient had a history of three years’
recurrent right-sided mandibular swelling and severe pain.
Otherwise his medical history was unremarkable. In the refer-
ring unit, the symptoms were first mistaken to be of parotid
origin and an ultrasound and sialography were obtained with
no significant findings. The patient was treated with repeated
courses of antibiotics with no relief in the symptoms. An
ortopantomogram (OPTG) was obtained and it showed a
lesion susceptible to chronic osteomyelitis and the patient
was treated with a course of oral clindamycin and metronida-
zole. During the treatment the symptoms reduced somewhat.
Later on, a magnetic resonance image (MRI) was obtained.
It showed a lesion (size 2 cm in diameter) in the mandible
and incidentally another lesion (size 3.5  2 cm) in the anterior
cranial base continuing into the nasal bony septum and eth-
moidal cells (Fig. 1). The patient was then asked about nasal
symptoms and a history of nasal obstruction and discharge
was given. A scintigraphy was also obtained and it showed
no other lesions. Both lesions in the mandible and in the sep-
tum were biopsied. Both biopsies showed fibrous dysplasia.
The patient was treated with a course of bisphosphonate
(disodium clodronate – Bonefos – 2400 mg a day for
6 months) during which the symptoms in the mandibular
region resolved completely. Eighteen months after the initial
referral, however, he developed blurred vision, occasional
double vision and his nasal congestion worsened, and he wasFigure 1 Pre-operative CT images. (A) Image with coronal section sh
skull base. (B) Axial section shows the width of the tumour, which isreferred again for consultation. Computed tomography
(CT)-scan showed a slow growth in tumour size in the nasal
cavity. It was measured at 5.2  2.2 cm in size. The surgery
was now indicated because of exacerbation of the nasal symp-
toms and development of occasional ocular symptoms. This
was presumed to be a possible symptom presentation of the
intracranial growth of the tumour. Combined approaches were
chosen as an operative technique. The neurosurgeon per-
formed an anterior craniotomy through a coronal incision.
During the craniotomy, a neurosurgeon completed the subto-
tal resection of the tumour using dissectors and curettes. The
dural defect was then repaired with one piece of temporal fas-
cia, fibrin glue and an EthisorbTM Dura Patch. The residual
tumour in the nasal cavity was then resected endoscopically
through the nose by an ear, nose and throat specialist using
endoscopic sinus surgery instruments and angled scopes. The
patient had no immediate complications and was discharged
a few days later. The follow-up CT nearly two years after
the surgery showed an ‘‘egg-shell” of the bony septum
filled with retention fluid but no residual tumour growth. In
the control visit 10 years later, in 2014, the patient was
symptom-free.
3. Discussion
Fibrous dysplasia represents a rare benign bony tumour that
occurs predominantly in young adults. The most common
location is the thorax and extremities, and it is very rarely seen
in the head and neck region. It has been reported that
50–100% of patients with a polyostotic form of the disease have
craniofacial involvement whereas in the monostotic form only
10% have a lesion in the head and neck region. In
craniofacial involvement surgery is indicated if the lesion com-
promises vision or aesthetics or causes other significant discom-
fort.10 A recent report of 26 patients showed cranial
involvement of the fibrous dysplasia, including the frontal,
parietal, sphenoidal, and occipital bones in 13 (52%) patients.
The tumour was located in the maxillary bone in 9 (33%)
patients. Temporal bone involvement was found in 3 (11%)
patients. One patient (4%) had mandibular involvement.11 Eth-ows a huge fibrous dysplasia in nasal septum reaching through the
passing from skull base defect.
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form of the disease involving the ethmoid bone and nasal sep-
tum has not been previously reported in the literature.
We assumed that our patient’s visual symptoms were
caused by the optic nerve being irritated by the tumour. A
review of the literature showed that the pathogenesis of the
visual symptoms is not fully understood yet. It has been pro-
posed that disturbances in the venous drainage of the optic
nerve and ultimately decreased retinal perfusion could be the
underlying mechanism. Other theories include traction on the
optic nerve, spontaneous haemorrhage or sinus mucocele for-
mation.10 It has generally been accepted that tumours encasing
the optic nerve should be resected and a decompression of the
optic nerve should be performed. Some authors have suggested
that decompression should be done prophylactically in cases
with optic nerve involvement. However, a recent study showed
that in a series of 107 optic nerves that were 100% encased,
88% exhibited no evidence of optic neuropathy. There was
no difference in age between groups with less than 50%,
50–99%, and 100% encasement, and patients with optic neu-
ropathy were not older than those without optic neuropathy.
These data support the conclusion that encasement does not
progress with age and that increasing age does not necessarily
bring with it the likelihood of optic neuropathy and blindness.
Based on this evidence, the authors do not recommend pro-
phylactic decompression on patients without symptoms merely
as an attempt to prevent possible future optic neuropathy. The
authors also show that vision loss is more often associated with
either growth hormone excess related to MAS or an aneurys-
mal bone cyst.12 Our patient reported intermittent blurred
vision and double vision although CT showed no direct optic
nerve involvement. Postoperatively all the visual symptoms
were resolved, but the primary reason for the double vision
and blurred vision remained unclear.
4. Conclusion
Fibrous dysplasia is a benign bone lesion characterised by
progressive replacement of normal bone by fibrous tissues.
The clinical picture is variable from asymptomatic patients to
patients with severe symptoms presenting as pain and patho-
logical fractures. Fibrous dysplasia and especially a polyostotic
form of fibrous dysplasia is a real rarity that presents diagnostic
and treatment challenges to us. As our case demonstrates, bony
lesions in the mandibular region can sometimes mimic soft tis-
sue problems. One should always strive for a histological or atleast a radiological diagnosis, especially when treatment
attempts have failed. This case also demonstrates the need for
careful monitoring of tumours located in areas where the
tumour growth can lead to possibly devastating complications.
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